MUC1 and ovarian carcinoma: With respect to the former, the in vivo behavior of [89Zr]Zr-DFO-AR20.5 in mice bearing subcutaneous MUC1-positive ovarian cancer xenografts mirrors that of other 89Zr-labeled radioimmunoconjugates.